Jagsonpal Pharmaceuticals Limited — Others, 03-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Jagsonpal Pharmaceuticals Limited has submitted a certificate to comply with SEBI regulations concerning dematerialization for the quarter ended December 31, 2024. The certificate confirms that securities received for dematerialization have been listed on the relevant stock exchanges and that the original certificates have been canceled following verification.

This initiative underscores the company's commitment to regulatory compliance and operational efficiency, reinforcing investor confidence. As the company streamlines its share processes, it could potentially enhance shareholder engagement and operational transparency, presenting a positive outlook for investors.